Legal Opinion
Tongue v. Sanofi
Court of Appeals for the Second Circuit
Decided March 4, 2016No. Nos. 15-588-cv, 15-623-cvPublishedCited by 212 opinions
1Opinion of the Court
BARRINGTON D. PARKER, Circuit Judge.
In these related cases, Plaintiffs allege that the pharmaceutical company Sanofi, along with its predecessor and three company executives, made materially false or misleading statements regarding its breakthrough drug, Lemtrada, designed to treat multiple sclerosis (“MS”). Plaintiffs allege that while Lemtrada was undergoing Phase III clinical trials prior to FDA approval, Sanofi misled investors by failing to disclose that the FDA had repeatedly expressed concern with Sanofi’s use of single-blind studies and had encouraged Sanofi to use double-blind…
2Cases cited13 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- ATSI Communications, Inc. v. Shaar Fund, Ltd.Court of Appeals for the Second Circuit · 2007
- Matrixx Initiatives, Inc. v. SiracusanoSupreme Court of the United States · 2011
- Securities and Exchange Commission v. First Jersey Securities, Inc. And Robert E. BrennanCourt of Appeals for the First Circuit · 1996
8 more not listed; retrieve them via the Exa API.
3Cited by212 opinions
- In re Vivendi, S.A. Secs. Litig.Court of Appeals for the Second Circuit · 2016
- City of Dearborn Heights Act 345 Police & Fire Retirement System v. Align Technology, Inc.Court of Appeals for the Ninth Circuit · 2017
- Progressive Credit Union, Taxi Medallion Owner Driver Ass'n, Inc. v. City of N.Y.Court of Appeals for the Second Circuit · 2018
- Doubleline Capital LP v. Odebrecht Fin., Ltd.District Court, S.D. Illinois · 2018
- Cavello Bay Reinsurance Ltd. v. Shubin SteinCourt of Appeals for the Second Circuit · 2021
207 more not listed; retrieve them via the Exa API.